LATEST ALERTS
Pressure has mounted on the federal government to regulate CBD products in the years since the 2018 Farm Bill passed. However, there has been a stalemate between Congress and the Food and Drug Administration (FDA), with each side pointing the finger at each other to act and leaving little hope for a break-through in the near future.
Despite most states legalising cannabis for medical and/or recreational use and wide popular support for legalisation, the federal government is only likely to make modest reforms to cannabis policy in the near future.
This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well as medical and recreational cannabis.
